Inhibition of fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development

American Journal of Pathology

Volumn 179, Issue 2, 2011, Pages 725-732

  Xiao, Zuoxiang ^a   Mohamood, Abdiaziz S ^a   Uddin, Sophia ^a   Gutfreund, Rachel ^a   Nakata, Chiaki ^a   Marshall, Andrew ^a   Kimura, Hiroaki ^a   Caturegli, Patrizio ^a   Womer, Karl L ^a   Huang, Yanfei ^a   Jie, Chunfa ^a   Chakravarti, Shukti ^a   Schneck, Jonathan P ^a   Yagita, Hideo ^b   Hamad, Abdel Rahim A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; FAS LIGAND; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE MUTATION; HEMATOPOIETIC CELL; IN VIVO STUDY; INSULITIS; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE;

ANIMALS; CELL PROLIFERATION; CELL SEPARATION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; GENOTYPE; HOMOZYGOTE; IMMUNE SYSTEM; INSULIN; INTERLEUKIN-10; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; MUTATION; T-LYMPHOCYTES;

EID: 80052501666     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.04.016     Document Type: Article

References (47)

1. D. Ashany, A. Savir, N. Bhardwaj, and K.B. Elkon Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway J Immunol 163 1999 5303 5311
2. Z. Guo, M. Zhang, H. An, W. Chen, S. Liu, J. Guo, Y. Yu, and X. Cao Fas ligation induces IL-1beta-dependent maturation and IL-1beta-independent survival of dendritic cells: different roles of ERK and NF-kappaB signaling pathways Blood 102 2003 4441 4447 (Pubitemid 37494108)
3. Z. Guo, M. Zhang, H. Tang, and X. Cao Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines Blood 106 2005 2033 2041 (Pubitemid 41291717)
4. M.J. Pinkoski, and D.R. Green Fas ligand, death gene Cell Death Differ 6 1999 1174 1181 (Pubitemid 30047894)
5. M. Rescigno, V. Piguet, B. Valzasina, S. Lens, R. Zubler, L. French, V. Kindler, J. Tschopp, and P. Ricciardi-Castagnoli Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses J Exp Med 192 2000 1661 1668
6. Y. Tada, J. O-Wang, Y. Takiguchi, K. Tatsumi, T. Kuriyama, S. Okada, T. Tokuhisa, S. Sakiyama, and M. Tagawa Cutting edge: a novel role for Fas ligand in facilitating antigen acquisition by dendritic cells J Immunol 169 2002 2241 2245 (Pubitemid 34920963)
7. M. Lenardo, F. Chan, F. Hornug, H. McFarland, R. Siegel, J. Wang, and L. Zheng Mature T lymphocytes apoptosis-immune regulation in a dynamic and unpredictable antigenic environment Annu Rev Immunol 17 1999 221 253 (Pubitemid 29241124)
8. T. Takahashi, M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand Cell 76 1994 969 976 (Pubitemid 24106378)
9. R. Watanabe-Fukunaga, C. Brannan, N. Copeland, N. Jenkins, and S. Nagata Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Nature 356 1992 314 317
10. G.H. Fisher, F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middelton, A.Y. Lin, W. Strober, M.J. Lenardo, and J.M. Puck Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome Cell 81 1995 935 946
11. A.R. Hamad Analysis of gene profile, steady state proliferation and apoptosis of double-negative T cells in the periphery and gut epithelium provides new insights into the biological functions of the Fas pathway Immunol Res 47 2010 134 142
12. S. Nagata, and T. Suda Fas and Fas ligand: lpr and gld mutations Immunol Today 16 1995 39 43
13. D.A. Hildeman, Y. Zhu, T.C. Mitchell, P. Bouillet, A. Strasser, J. Kappler, and P. Marrack Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim Immunity 16 2002 759 767 (Pubitemid 34786475)
14. A.L. Snow, J.B. Oliveira, L. Zheng, J.K. Dale, T.A. Fleisher, and M.J. Lenardo Critical role for BIM in T cell receptor restimulation-induced death Biol Direct 3 2008 34
15. P.B. Stranges, J. Watson, C.J. Cooper, C.M. Choisy-Rossi, A.C. Stonebraker, R.A. Beighton, H. Hartig, J.P. Sundberg, S. Servick, G. Kaufmann, P.J. Fink, and A.V. Chervonsky Elimination of antigen-presenting cells and autoreactive T cells by fas contributes to prevention of autoimmunity Immunity 26 2007 629 641 (Pubitemid 46756349)
16. B.L. Lohman, E.S. Razvi, and R.M. Welsh T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions J Virol 70 1996 8199 8203 (Pubitemid 26339138)
17. A.S. Mohamood, D. Bargatze, Z. Xiao, C. Jie, H. Yagita, D. Ruben, J. Watson, S. Chakravarti, J.P. Schneck, and A.R. Hamad Fas-mediated apoptosis regulates the composition of peripheral alphabeta T cell repertoire by constitutively purging out double negative T cells PLoS One 3 2008 e3465
18. A.V. Chervonsky, Y. Wang, F.S. Wong, I. Visintin, R.A. Flavell, C.A. Janeway Jr, and L.A. Matis The role of Fas in autoimmune diabetes Cell 89 1997 17 24 (Pubitemid 27180581)
19. S. Kim, K.A. Kim, D.Y. Hwang, T.H. Lee, N. Kayagaki, H. Yagita, and M.S. Lee Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved J Immunol 164 2000 2931 2936 (Pubitemid 30148950)
20. H.E. Thomas, R. Darwiche, J.A. Corbett, and T.W. Kay Evidence that beta cell death in the nonobese diabetic mouse is Fas independent J Immunol 163 1999 1562 1569 (Pubitemid 29352780)
21. J. Allison, and A. Strasser Mechanisms of beta cell death in diabetes: a minor role for CD95 Proc Natl Acad Sci U S A 95 1998 13818 13822 (Pubitemid 28523056)
22. I. Apostolou, Z. Hao, K. Rajewsky, and H. von Boehmer Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes J Exp Med 198 2003 1103 1106 (Pubitemid 37248625)
23. A.Y. Savinov, A. Tcherepanov, E.A. Green, R.A. Flavell, and A.V. Chervonsky Contribution of Fas to diabetes development Proc Natl Acad Sci U S A 100 2003 628 632 (Pubitemid 36126103)
24. X. Su, Q. Hu, J.M. Kristan, C. Costa, Y. Shen, D. Gero, L.A. Matis, and Y. Wang Significant role for Fas in the pathogenesis of autoimmune diabetes J Immunol 164 2000 2523 2532 (Pubitemid 30115482)
25. R.M. Siegel, J.K. Frederiksen, D.A. Zacharias, F.K. Chan, M. Johnson, D. Lynch, R.Y. Tsien, and M.J. Lenardo Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations Science 288 2000 2354 2357 (Pubitemid 30448157)
26. A.S. Mohamood, M.L. Guler, Z. Xiao, D. Zheng, A. Hess, Y. Wang, H. Yagita, J.P. Schneck, and A.R. Hamad Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically Am J Pathol 171 2007 97 106 (Pubitemid 47339230)
27. M. Nakayama, M. Nagata, H. Yasuda, K. Arisawa, R. Kotani, K. Yamada, S.A. Chowdhury, S. Chakrabarty, Z.Z. Jin, H. Yagita, K. Yokono, and M. Kasuga Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes Diabetes 51 2002 1391 1397 (Pubitemid 34826604)
28. Z. Hao, B. Hampel, H. Yagita, and K. Rajewsky T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis J Exp Med 199 2004 1355 1365 (Pubitemid 38685727)
29. N. Kayagaki, N. Yamaguchi, F. Nagao, S. Matsuo, H. Maeda, K. Okumura, and H. Yagita Polymorphism of murine Fas ligand that affects the biological activity Proc Natl Acad Sci U S A 94 1997 3914 3919 (Pubitemid 27180473)
30. T. Matsushita, K. Yanaba, J.D. Bouaziz, M. Fujimoto, and T.F. Tedder Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression J Clin Invest 118 2008 3420 3430
31. P. Hoglund, J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes J Exp Med 189 1999 331 339 (Pubitemid 29063254)
32. J.D. Katz, B. Wang, K. Haskins, C. Benoist, and D. Mathis Following a diabetogenic T cell from genesis through pathogenesis Cell 74 1993 1089 1100 (Pubitemid 23289465)
33. C. Mauri, D. Gray, N. Mushtaq, and M. Londei Prevention of arthritis by interleukin 10-producing B cells J Exp Med 197 2003 489 501 (Pubitemid 36278604)
34. A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R.S. Blumberg, and A.K. Bhan Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation Immunity 16 2002 219 230 (Pubitemid 34211962)
35. A. O'Garra, F.J. Barrat, A.G. Castro, A. Vicari, and C. Hawrylowicz Strategies for use of IL-10 or its antagonists in human disease Immunol Rev 223 2008 114 131 (Pubitemid 351986180)
36. B. Balasa, K. Van Gunst, N. Jung, J.D. Katz, and N. Sarvetnick IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse Cell Immunol 202 2000 97 102 (Pubitemid 30612716)
37. K.J. Pennline, E. Roque-Gaffney, and M. Monahan Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse Clin Immunol Immunopathol 71 1994 169 175 (Pubitemid 24147233)
38. S. Hussain, and T.L. Delovitch Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner J Immunol 179 2007 7225 7232
39. K.W. Moore, R. de Waal Malefyt, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 2001 683 765 (Pubitemid 32368050)
40. D.V. Serreze, H.D. Chapman, C.M. Post, E.A. Johnson, W.L. Suarez-Pinzon, and A. Rabinovitch Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation J Immunol 166 2001 1352 1359 (Pubitemid 32060298)
41. Z. Chen, A.E. Herman, M. Matos, D. Mathis, and C. Benoist Where CD4+CD25+ T reg cells impinge on autoimmune diabetes J Exp Med 202 2005 1387 1397 (Pubitemid 41668741)
42. B.L. Rodriguez, W.Y. Fujimoto, E.J. Mayer-Davis, G. Imperatore, D.E. Williams, R.A. Bell, R.P. Wadwa, S.L. Palla, L.L. Liu, A. Kershnar, S.R. Daniels, and B. Linder Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study Diabetes Care 29 2006 1891 1896 (Pubitemid 44156648)
43. R.P. Wadwa Cardiovascular disease risk in youth with diabetes mellitus Rev Endocr Metab Disord 7 2006 197 204 (Pubitemid 46072643)
44. M. Ejrnaes, M.G. von Herrath, and U. Christen Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies Clin Dev Immunol 13 2006 337 347 (Pubitemid 44950049)
45. M.J. Haller, M.A. Atkinson, and D.A. Schatz The road not taken: a path to curing type 1 diabetes Eur J Immunol 39 2009 2054 2058
46. M. von Herrath Combination therapies for type 1 diabetes: why not now Immunotherapy 2 2010 289 291
47. L. Zhang, R. Gianani, M. Nakayama, E. Liu, M. Kobayashi, E. Baschal, L. Yu, S. Babu, A. Dawson, K. Johnson, M. Jahromi, T. Aly, P. Fain, J. Barker, M. Rewers, and G.S. Eisenbarth Type 1 diabetes: chronic progressive autoimmune disease Novartis Found Symp 292 2008 85 94